Teprotumumab Biosimilar(Anti-IGF1R / CD221 Reference Antibody)
ORB2703819
Product group Antibodies
Overview
- SupplierBiorbyt
- Product NameTeprotumumab Biosimilar(Anti-IGF1R / CD221 Reference Antibody)
- Delivery Days Customer10
- CertificationResearch Use Only
- ClonalityMonoclonal
- ConjugateUnconjugated
- Scientific DescriptionTeprotumumab is an IGF-1 receptor (IGF-1R) blocking human monoclonal antibody. Teprotumumab binds to the ligand binding extracellular alpha-subunit domain of IGF-1R. Teprotumumab inhibits TSH and IGF-1 action in fibrocytes. Teprotumumab attenuates TSH-dependent IL-6 and IL-8 expression and Akt phosphorylation. Teprotumumab can be used for thyroid-associated ophthalmopathy research.
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC12352203